| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e6e4a54a61ccf2f9cb4d46d5160eafe6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dae64f1240832a53dc693a851c46d9f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7bdcebe7b77c35be27a736b158e3cd7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7469b059074563fe08a732e81bdb4d80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aef3b508fd8af4c87f2dc53499e72cd2 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2330-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-141
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088 |
| filingDate |
2010-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33561d078a74a4756faa5b7c15e6eaa3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e611558eafadfecb278a6d360fee78a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2385684a59abf376f94425fcfcc1a0dc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dde18b7b76834cb52ca96776670b1be4 |
| publicationDate |
2011-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2010122109-A9 |
| titleOfInvention |
Method for the treatment of acute myeloid leukemia |
| abstract |
The invention is in the field of molecular medicine and provides methods for the treatment of acute myeloid leukemia. These methods are based on the observation that microRNA-9 and microRNA-9* are involved in the pathogenesis of the disease in that the overexpression of microRNA-9/9* block myeloid differentiation in vitro. More in particular, microRNA-9/9* were found to play a role in leukemic transformation in acute myeloid leukemia. |
| priorityDate |
2009-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |